<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00969202</url>
  </required_header>
  <id_info>
    <org_study_id>SDRS0001</org_study_id>
    <nct_id>NCT00969202</nct_id>
  </id_info>
  <brief_title>Stereotactic Hypofractionated Radiosurgery for Early Stage Prostate Cancer</brief_title>
  <official_title>Phase 1 Study of Stereotactic Hypofractionated Radiosurgery of Low Grade Prostate Cancer/Early Stage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>San Diego Radiosurgery</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>San Diego Radiosurgery</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this trial is to evaluate a short course of very focused (stereotactic)
      external beam radiation therapy for the treatment of early stage prostate cancer.

      The investigators will gather scientific information about the tolerance and side effects
      this type of radiation. The investigators will then compare these results with those of
      standard 8 week course of external beam radiation therapy to see if this study treatment is
      equally or more effective in treating prostate cancer.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2009</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">August 2016</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PSA decline measured through laboratory testing.</measure>
    <time_frame>One month following radiosurgery through 5 year follow up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life in relation to urinary, bowel and sexual function. Measured through a questionnaire at each follow up visit.</measure>
    <time_frame>One month following radiosurgery through 5 years follow up.</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>Stereotactic Radiosurgery using NovalisTx</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single arm study using the Novalis Tx to perform radiosurgery to treat low grade prostate cancer.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Stereotactic Radiosurgery using the Novalis Tx</intervention_name>
    <description>Five treatments given every other day.</description>
    <arm_group_label>Stereotactic Radiosurgery using NovalisTx</arm_group_label>
    <other_name>Novalis Tx</other_name>
    <other_name>Novalis</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Histologically confirmed adenocarcinoma of the prostate

          -  Gleason score â‰¤ 6 and low volume Gleason 7 (3+4)

          -  PSA &lt; 10

          -  Clinical Stage of T2a or less

          -  Ability to understand and the willingness to sign a written informed consent document

        Exclusion Criteria:

          -  Prior radiation treatment for prostate cancer

          -  Gleason score &gt; 7

          -  PSA &gt; 10

          -  Clinical Stage of T2b or greater
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>P. Brian Volpp, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>San Diego Radiosurgery/X-Ray Medical Group-Radiation Oncology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jennifer Joiner</last_name>
    <phone>760-739-3185</phone>
    <email>Jennifer.joiner@palomarhealth.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jeremy Legg</last_name>
    <phone>615-920-1282</phone>
    <email>jlegg@Allianceoncology.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>San Diego Radiosurgery at Palomar Medical Center</name>
      <address>
        <city>Escondido</city>
        <state>California</state>
        <zip>92025</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Joiner</last_name>
      <phone>760-739-3185</phone>
      <email>Jennifer.joiner@palomarhealth.org</email>
    </contact>
    <investigator>
      <last_name>Lori A Coleman, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>P. Brian Volpp, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kelly D Dewitt, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Barry Uhl, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Geoffrey Weinstein, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Phillip Zentner, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 28, 2009</study_first_submitted>
  <study_first_submitted_qc>August 31, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2009</study_first_posted>
  <last_update_submitted>November 17, 2015</last_update_submitted>
  <last_update_submitted_qc>November 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 18, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Prostate Cancer</keyword>
  <keyword>Cancer of the Prostate</keyword>
  <keyword>Prostate Tumor</keyword>
  <keyword>Novalis Tx</keyword>
  <keyword>Novalis</keyword>
  <keyword>Stereotactic Radiosurgery</keyword>
  <keyword>Radiosurgery</keyword>
  <keyword>Radiation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

